Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.
Int J Cancer. 2018 Oct 15;143(8):1954-1962. doi: 10.1002/ijc.31604. Epub 2018 Aug 9.
Testicular germ cell tumors (TGCTs) are a clinically and pathologically heterogeneous disease, and little is known of its genetic basis. Only low susceptibility risk loci have been identified for both sporadic and familial cases. Therefore, we tried to identify new susceptibility genes responsible for familial testicular cancer that may contribute to increasing our knowledge about the genetic basis of the disease. Nineteen Spanish families with at least two affected individuals with TGCT were selected. WES was performed on those individuals using an Illumina Hiseq2000 sequencing platform. Data were analyzed under a monogenic and polygenic model of inheritance, and candidate variants were evaluated in a case-control association study performed on 391 Spanish sporadic cases and 1,170 healthy Spanish controls. Results were replicated in a second series consisting of 101 TGCTs from the Cancer Genome Atlas (TGCA) and 27,000 controls from the Exome Aggregation Consortium (ExAC) database. Logistic regression was carried out to analyze the association strength (risk) of candidate variants obtained among cases and controls in different populations. Despite the sample size, we detected a significant earlier age of onset in familial TGCT (28y) than sporadic cases (33y), using a Mann-Whitney U test. We identified significant variants in the comparative study of TGCT cases (391) versus controls (almost 1,170), and three of them [PLEC (OR = 6.28, p = 6.42 × 10 ) (p.Arg2016Trp), EXO5 (OR = 3.37, p = 4.82 × 10 ) (p.Arg344AlafsTer10) and DNAH7 (OR = 1.64, p = 0.048)] were replicated as potential candidates that may contribute to explaining the genetic basis of TGCT.
睾丸生殖细胞肿瘤(TGCTs)是一种临床表现和病理表现均具有异质性的疾病,其遗传基础知之甚少。仅确定了散发性和家族性病例的低易感性风险基因座。因此,我们试图确定新的易感性基因,这些基因可能导致家族性睾丸癌,并有助于增加我们对该疾病遗传基础的认识。选择了 19 个至少有两个 TGCT 受累个体的西班牙家族。对这些个体进行了外显子组测序(WES),使用 Illumina Hiseq2000 测序平台。根据单基因和多基因遗传模型对数据进行分析,并在 391 名西班牙散发性病例和 1170 名健康西班牙对照的病例对照关联研究中评估候选变异。在由癌症基因组图谱(TCGA)的 101 个 TGCT 和外显子组聚合联盟(ExAC)数据库的 27000 个对照组成的第二个系列中复制了结果。逻辑回归用于分析在不同人群中病例和对照中获得的候选变异的关联强度(风险)。尽管样本量较小,但使用曼-惠特尼 U 检验,我们在家族性 TGCT(28y)与散发性病例(33y)之间检测到更早的发病年龄。在 TGCT 病例(391)与对照(近 1170)的比较研究中,我们发现了显著的变异,其中三个 [PLEC(OR=6.28,p=6.42×10-8)(p.Arg2016Trp),EXO5(OR=3.37,p=4.82×10-8)(p.Arg344AlafsTer10)和 DNAH7(OR=1.64,p=0.048)]作为潜在候选基因被复制,可能有助于解释 TGCT 的遗传基础。